Consilium Strategic Communications’ Annual Healthcare Conference, sponsored by Citi, Cooley and Stifel is now in its 10th year and brings together leading experts from the healthcare and biotechnology industries to discuss the key themes and issues currently facing the sector. 

REGISTER TO ATTEND

 

 

REGISTER TO JOIN ONLINE

 

 

Agenda

View

close

Agenda

12:00-13:00

Lunch and networking

13:00-13:05

Introduction from Amber Fennell, Partner and Co-Founder, Consilium Strategic Communications

13:05-13:50

Bursting the bubbles? Are hot therapeutic areas of investor focus a help or a hindrance to innovation?

Are hot therapeutic areas of investor focus a help or a hindrance to innovation? Ultimately we need to be bringing significant innovation to patients and supporting physicians to radically change treatment protocols - but does the industry skew too much towards what makes most financial sense? In reference to the next panel, what are the areas that we are not focusing on that we should?

13:50-14:35

Reimagining Healthcare: Engineering a healthcare ecosystem for the 21st century

The COVID-19 pandemic provided a wake-up call to global healthcare systems. But with rising inflation and the ever-increasing pressures on implementing and funding public health, there are many ways in which the industry is struggling to keep pace with the times. What are the biggest challenges for companies trying to bring innovations to the market against this backdrop and how should we overcome these? And what does society need from our industry?

14:35-15:20

Break

15:20-16:05

Managing a downturn, market and financing considerations in a bear market

We are in the middle of one of the most challenging periods in capital markets activity since the financial crisis of 2008-2009 and healthcare, along with other innovation-based sectors, has suffered in 2022. Difficult financing environments force companies to focus on priorities and can lead to painful decisions but ultimately can spur genuine innovation and bring winning companies and creative new financing models to the fore. This panel assembles people with experience of both negotiating difficult funding environments and those who invest professionally to deliver their thoughts on how to ride choppy waves.

16:05-16:50

Fireside chat: A discussion between Justin Stebbing, Professor of Oncology, Editor of Oncogene and Hannah Kuchler, Global Pharmaceuticals Correspondent at the Financial Times

16:50-17:00

Closing remarks

17:00-18:30

Networking drinks

Information

View

close

Information

Time: 12:00-18:30

Address: Chartered Accountants' Hall, 1 Moorgate Pl, London EC2R 6EA

Closest tube stations: Bank, St Paul’s, Moorgate, Liverpool Street

 

Nearby hotels: Apex London Wall, South Place Hotel, Threadneedles

 

Lunch and refreshments will be provided.

 

Live webcast of the event will also be available closer the time.

 

If you have any questions, please contact admincsc@consilium-comms.com.

Speakers

View

close

Speakers

Panel 1: Bursting the bubbles? Are hot therapeutic areas of investor focus a help or a hindrance to innovation?

Moderator - Nicola Maguire, Partner, Cooley

Ros Deegan, Chief Executive Officer, OMass Therapeutics

Nick Keher, Chief Financial Officer, BenevolentAI

Linden Thomson, Fund Manager, AXA Investment Managers 

Lars Wilde, Chief Executive Officer, Pangea Botanica

 

Panel 2: Reimagining Healthcare: Engineering a healthcare ecosystem for the 21st century

Moderator - Jessica Hodgson, Senior Associate Partner, Consilium Strategic Communications

Hugo Fry, Chief Executive Officer, RQ Biotechnology

Melanie Lee, Chief Executive Officer, LifeArc

Lachlan MacKinnon, Chief Executive Officer and Co-Founder, Replay

Miroslav Reljanovic, Founder and Executive Chairman, Ergomed

 

Panel 3: Managing a downturn, market and financing considerations in a bear market

Moderator - Nick Moore, Managing Director, Stifel

Lisa Anson, Chief Executive Officer, Redx Pharma

Tom Burt, Partner, Crossover Strategy, Sofinnova

Georgy Egorov, Chief Financial Officer/ Board member

Jorge Santos da Silva, Chief Executive Officer and Co-Founder, MoonLake Immunotherapeutics

Sander Slootweg, Managing Partner and Co-founder, Forbion

 

Fireside chat: A discussion between Justin Stebbing, Professor of Oncology, Editor of Oncogene and Hannah Kuchler, Global Pharmaceuticals Correspondent at the Financial Times

Moderator - Hannah Kuchler, Global Pharma Correspondent, Financial Times

Justin Stebbing, Professor of Oncology, Editor of Oncogene

Sponsors

View

close

Sponsors

Citi is a preeminent banking partner for institutions with cross-border needs, a global leader in wealth management and a valued personal bank in its home market of the United States. Citi does business in more than 160 countries and jurisdictions, providing corporations, governments, investors, institutions and individuals with a broad range of financial products and services.

Additional information may be found at www.citigroup.com

 

 

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 1,500 lawyers across 17 offices in the United States, Asia and Europe, and a total workforce of 3,300.

Additional information may be found at www.cooley.com

 

Stifel Financial Corp. (NYSE: SF) is a financial services holding company headquartered in St. Louis, Missouri, that conducts its banking, securities, and financial services business through several wholly owned subsidiaries. Stifel’s broker-dealer clients are served in the United States through Stifel, Nicolaus & Company, Incorporated, including its Eaton Partners business division; Keefe, Bruyette & Woods, Inc.; Miller Buckfire & Co., LLC and Stifel Independent Advisors, LLC. The Company’s broker-dealer affiliates provide securities brokerage, investment banking, trading, investment advisory, and related financial services to individual investors, professional money managers, businesses, and municipalities. Stifel Bank and Stifel Bank & Trust offer a full range of consumer and commercial lending solutions. Stifel Trust Company, N.A. and Stifel Trust Company Delaware, N.A. offer trust and related services.

Additional information may be found at www.stifel.com

 

Webcast Sponsor